Substance with epidermal growth factor receptor inhibitor mechanism of action (substance)
| Code | 409402009 |
|---|---|
| Semantic tag | substance |
| Module | international |
| Definition | defined |
| Effective time | 20180131 |
372688009Antineoplastic agent
substance
426265004Protein kinase inhibitor
substance
1162751008Amivantamab
substance
409400001Cetuximab
substance
414123001Erlotinib
substance
426686007Erlotinib hydrochloride
substance
407100002Gefitinib
substance
784176007Human epidermal growth factor receptor 2 inhibitor
substance
426238006Lapatinib ditosylate
substance
1269168000Lapatinib ditosylate anhydrous
substance
725960003Lapatinib ditosylate monohydrate
substance
933451401000036107Lazertinib
substance
579861000202108Lazertinib mesilate monohydrate
substance
1373927003Lazertinib mesylate
substance
40609711000001106Mobocertinib
substance
40618011000001101Mobocertinib succinate
substance
716015005Necitumumab
substance
765360008Nimotuzumab
substance
716032009Osimertinib
substance
734660003Osimertinib mesylate
substance
423259008Panitumumab
substance
418260004Vandetanib
substance